title: Does complement activation control 'tissue trafficking' by C3a and C5a anaphylotoxin generation?
authors.affiliation: Department of Pathology, University of Michigan, Ann Arbor, USA.
authors.forename: K E
authors.initials: KE
authors.lastname: Foreman
authors.forename: M M
authors.initials: MM
authors.lastname: Glovsky
authors.forename: R L
authors.initials: RL
authors.lastname: Warner
authors.forename: S J
authors.initials: SJ
authors.lastname: Horvath
authors.forename: P A
authors.initials: PA
authors.lastname: Ward
mesh_terms: D018821:CD18 Antigens / Q000096:biosynthesis; D002448:Cell Adhesion / Q000187:drug effects; D002478:Cells, Cultured; D003167:Complement Activation; D015926:Complement C3a / Q000096:biosynthesis* / Q000494:pharmacology; D015936:Complement C5a / Q000096:biosynthesis* / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects; D006801:Humans; D016177:Macrophage-1 Antigen / Q000096:biosynthesis; D009504:Neutrophils / Q000187:drug effects; D011994:Recombinant Proteins / Q000494:pharmacology; D014471:Umbilical Veins; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D018821:CD18 Antigens; D016177:Macrophage-1 Antigen; D011994:Recombinant Proteins; D015926:Complement C3a; D015936:Complement C5a